Rossari Biotech tanks 20%, hits 52-week low post December quarter results

The management said raw material volatility has impacted profitability performance during the quarter
15-02-2022
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Rossari Biotech Limited has informed the Exchange regarding a press release dated February 14, 2022, titled "Rossari Biotech announces Q3 & 9M FY22 results".
14-02-2022
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Earnings Conference Call for investors and analysts on Tuesday, February 15, 2022 at 05:30 P.M. IST
12-02-2022
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Approval Of Quarterly Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021

Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021.
08-02-2022
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Rossari Biotech Limited has informed the Exchange regarding Allotment of 1500 Shares
04-02-2022
Bigul

Rossari Biotech Ltd - 543213 - Cancellation of Board Meeting

The Board Meeting to be held on 29/01/2022 Stands Cancelled.
28-01-2022
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Revision in Timing of Earnings Conference Call for investors and analysts for Q3 & 9M FY21-22
26-01-2022
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Earnings Conference Call for investors and analysts on Monday, January 31, 2022 at 04:30 P.M. IST
24-01-2022
Next Page
Close

Let's Open Free Demat Account